PLAMOTAMAB
UNII 5ENX424FNF
Substance Identification & Data
This profile provides standardized clinical and technical data for Plamotamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5ENX424FNF.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2138442-31-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
5ENX424FNF
2138442-31-4
N/A
Detailed Substance Profile
Preferred Name
PLAMOTAMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11020
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
GH-170
Identifier assigned by the United States Adopted Names Council.
Substance Type
PLAMOTAMAB
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Plamotamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
PLAMOTAMAB
Common Names & Synonyms
ANTI-CD20/CD3 MONOCLONAL ANTIBODY XMAB13676
PLAMOTAMAB [USAN]
Plamotamab [WHO-DD]
plamotamab [INN]
Systematic Nomenclature
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB13676 .GAMMA.1-CHAIN), (265->230'),(268->233')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB13676 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL XMAB13676 .KAPPA.-CHAIN
IMMUNOGLOBULIN G1-KAPPA MONOMER ANTI-(HOMO SAPIENS B-LYMPHOCYTE ANTIGEN CD20 (MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1, CD20 ANTIGEN)), LINKED TO SCFV-H-CH2-CH3 ANTI-(HOMO SAPIENS T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN (T-CELL SURFACE ANTIGEN T3/LEU-4 EPSILON CHAIN, CD3E ANTIGEN)), MONOCLONAL ANTIBODY, BISPECIFIC.GAMMA.1 HEAVY CHAIN ANTI-CD20 (1-450) (VH (HOMO SAPIENS IGHV1-3*01 (89%) (IGHD)-IGHJ2*01 (81%)) (8.8.14) (1-121)-HOMO SAPIENS IGHG1*03 (CH1(N91>D(212),R97>K(218)), CH2(E3>P(237),L4>V(238),L5>-(DEL),G6>A(239),S37>K(270),Q65>E(298)), CH3(L28>D(371),K30>S(373),N44>D(387),Q78>E(421),N81>D(424))) (122-450)) (224-213')-DISULFIDE WITH .KAPPA. LIGHT CHAIN ANTI-CD20 (1'-213') (V-KAPPA (HOMO SAPIENS IGKV1-16*01 (81%) IGKJ4*01)(5.3.9) (1'-106')-HOMO SAPIENS IGKC*01 (107'-213'))HEAVY CHAIN (SCFV-H-CH2-CH3) ANTI-CD3E (1''-485'') (VH (HOMO SAPIENS IGHV3-73*01 (87%) (IGHD)-IGHJ6*01 (91%)) (8.10.16) (1''-125'') TETRAKIS(GLYCYLLYSYLPROLYLGLYCYLSERYL) LINKER (126''-145'') V-LAMBDA (MUS MUSCULUS IGLV1*01 (81%)-IGLJ1*01/HOMO SAPIENS IGLV7-46*01 (77%) IGLJ3*02) (9.3.9) (146''-254'')-IGHG1*03 (DES-CH1, H(C5>S(259'')), CH2(E3>P(272''),L4>V(273''),L5>-(DEL),G6>A(274''),S37>K(305'')), CH3(E17>Q(395''),S24>K(402''))) (255''-485''))HETERODIMER (230-265'':233-268'')-BISDISULFIDE
IMMUNOGLOBULIN HALF-G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS MS4A1 (MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1, CD20) AND HOMO SAPIENS CD3 EPSILON (CD3E, LEU-4)), MONOCLONAL ANTIBODY, BISPECIFICGAMMA1 HEAVY CHAIN ANTI-MS4A1 (1-450) (VH (HOMO SAPIENS IGHV1-3*01 (88.8%)-(IGHD)-IGHJ2*01 (81.2%)) (8.8.14) (1-121)-HOMO SAPIENS IGHG1*03V (CH1 N114>D (212), R120>K (218) (122-219), HINGE 1-15 (220-234), CH2 E1.4>P (237), L1.2>V (238), G1.1>A (239), S29>K (270), Q84.2>E (298) (235-343), CH3 E12 (359), M14 (361), L24>D (371), K26>S (373), N44>D (387), Q97>E (421), N100>D (424) (344-448), CHS (449-450)) (122-450)),(224-213')-DISULFIDE WITH KAPPA LIGHT CHAIN ANTI-MS4A1 (1'-213') (V-KAPPA (HOMO SAPIENS IGKV1-16*01 (80.9%)-IGKJ4*01 (100%)) (5.3.9) (1'-106')-HOMO SAPIENS IGKC*01 (100%) A45.1 (152), V101 (190) (107'-213'))HEAVY CHAIN SCFV-H-CH2-CH3, ANTI-CD3E (1-485) (VH (HOMO SAPIENS IGHV3-73*01 (87.0%)-(IGHD)-IGHJ6*01 (90.9%)) (8.10.16) (1-125)-20-MER LINKER (126-145)-V-LAMBDA (MUS MUSCULUS IGLV1*01 (80.6%)-IGLJ1*01 (100%)/HOMO SAPIENS IGLV7-46*01 (76.8%)-IGHJ3*02 (100%)) (9.3.9) (146-254)-IGHG1*03 (HINGE 1-15 C5>S (259) (255-269)-CH2 E1.4>P (272), L1.2>V (273), G1.1>A (274), S29>K (305) (270-378),CH3 E12 (394), E13>Q (395), M14 (396), S20>K (402)(379-483), CHS (484-485)) (1-485))(230-265'':233-268'')-BISDISULFIDE
Technical Codes
XENP13676
XMAB-13676
XMAB13676
